Accelera Diagnostics, a new startup, will commercialise up to 21 pharmaceuticals licensed to Sunbelt.
New Mexico University’s Centre for Molecular Discovery and Nevada-based venture firm Sunbelt Technologies have signed an agreement that gives Sunbelt the option to license 21 potential pharmaceuticals. The commercialisation pipeline is to be managed by newly formed Accelera Diagnostics.
The potential new therapies could cover a wide range of diseases, from ovarian and breast cancer to leukaemia and stroke. Sunbelt is currently hiring a team of medical researchers and marketing experts to screen the research and pass the most promising…
